^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Lung Cancer Circulating Tumor DNA Multi-gene Mutation Combined Detection Kit

Company:
BGI Group
Type:
CE Marked
Related tests:
Evidence

News

almost3years
BGI has obtained CE Mark for its lung cancer and pan-cancer detection kits (BGI Group Press Release)
"BGI Genomics Co. LTD...announces that its Lung Cancer Library Reagent - Lung Cancer Circulating Tumor DNA Multi-gene Mutation Combined Detection Kit (Combinatorial Probe-Anchor Synthesis Sequencing Method), and Pan-Cancer Library Reagent - Solid Tumor Multi-gene Combined Detection Kit (Combinatorial Probe-Anchor Synthesis Sequencing Method) have got the CE mark in December 2021."
European regulatory
|
Lung Cancer Circulating Tumor DNA Multi-gene Mutation Combined Detection Kit • Solid Tumor Multi-gene Combined Detection Kit